Canadian Investment Regulatory Organization Trade Resumption – FMAN
VANCOUVER, BC, Oct. 3, 2024 /CNW/ – Trading resumes in: Company: Freeman Gold Corp. TSX-Venture Symbol: FMAN All Issues: Yes Resumption (ET): 8:00 AMAt the open CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halt
1101 White Cliff, LLC Completes $21 Million Acquisition of Vistas at Red Creek in San Angelo, TX
SAN ANGELO, Texas, Oct. 3, 2024 /PRNewswire/ — 1101 White Cliff, LLC announced the acquisition of residential property, Vistas at Red Creek in San Angelo, TX, for $21 million. This modern living community, located at 5751 Green Hill Road, was acquired on September 26, 2024, with a total Real P
Curaleaf Continues Florida Expansion with Opening of Port St. Lucie Dispensary
New location in Southeast Florida marks the Company’s 65th dispensary in the state and 151st nationwide STAMFORD, Conn., Oct. 3, 2024 /PRNewswire/ — Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading international provider
ZK International Group’s Breakthrough Win in the Shenzhen Gas Project is Expected to Propel Growth Amid China’s Economic Stimulus Which Should Exceed $284 Billion
WENZHOU, China, Oct. 3, 2024 /PRNewswire/ — ZK International Group Co., Ltd. (Nasdaq: ZKIN) (“ZK International” or the “Company”) is proud to announce that it has secured a significant contract with Shenzhen Gas Group for the Shenzhen Municipal Infrastructural Gas Pip
Canadian Investment Regulatory Organization Trade Resumption – PLUR
VANCOUVER, BC, Oct. 3, 2024 /CNW/ – Trading resumes in: Company: Plurilock Security Inc. TSX-Venture Symbol: PLUR All Issues: Yes Resumption (ET): 8:00 AM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are
The Largest Network of Research Sites Vetted to Execute Complexities of Cell & Gene Therapy (CGT) Trials Now Includes 1,500 Sites
Advarra’s Gene Therapy Ready (GTR) global site network expands to better support and accelerate the rapidly growing number of CGT investigational new drugs through approval COLUMBIA, Md., Oct. 3, 2024 /PRNewswire/ — Advarra, the market leader in regulatory review solutions and clinical
Paranjape Schemes Ties Up with Empire Grand for the Prestigious Thane Project called codename Lighthouse in the City
THANE, India, Oct. 3, 2024 /PRNewswire/ — Paranjape Schemes, a leading name in the Indian real estate sector, proudly announces its strategic partnership with Empire Grand for their Thane project – lighthouse in the city. This collaboration marks a significant milestone in both companiesR
NEW REPORT: One in Four Congressional Candidates Is a Millennial or Gen Zer
WASHINGTON, Oct. 3, 2024 /PRNewswire/ — More young Americans are running for Congress in 2024, with around 25% of candidates belonging to the youngest two generations, according to a new report released today by Future Caucus. The new report stands in contrast to the widespread narrative of po
Soligenix Announces Partnership with Sterling Pharma Solutions
U.S. Expansion of Synthetic Hypericin Active Ingredient Manufacturing PRINCETON, N.J., Oct. 3, 2024 /PRNewswire/ — Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where t
RevitaLash® Cosmetics’ RevitaBrow® Advanced Wins Highly Coveted Allure Best of Beauty Award for 12th Consecutive Year
VENTURA, Calif., Oct. 3, 2024 /PRNewswire/ — RevitaLash® Cosmetics is proud to announce its 12th consecutive Allure Best of Beauty Award. RevitaBrow® Advanced Eyebrow Conditioner has again received the honor of “Best Brow Conditioner,” further solidifying its status as an industr
